Inguinal hernia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene
Conditions
Interventions
Intervention 1: Intervention group: Half an hour before the patient leave the recovery department, the intervention group will receive 500 mg intravenous Methocarbamol (5 cc methocarbamol diluted with
Treatment - Drugs
Placebo
Intervention group: Half an hour before the patient leave the recovery department, the intervention group will receive 500 mg intravenous Methocarbamol (5 cc methocarbamol diluted with 5 cc normal sal
Control group: Half an hour before the patient leave the recovery department, the control group will receive 10 cc intravenous normal saline. Then they receive oral placebo tablets (similar to metocar
Sponsors
Vice Chancellor for research of Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age between 15 to 55 years old? Weight less than 100kg? Class I,II American Anesthesiology Association? Patient satisfaction. Exclusion criteria: Co-morbid severe or chronic systemic disease such as Asthma, Cardio-Pulmonary, Renal and Hepatic disease; Drug abuse in patients; Evidence of allergic reactions to Methocarbamol, Ibuprofen and Pethidine? Patient dissatisfaction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 1,6,12,24 hour After the operation, and also a week after the operation. Method of measurement: Visual Analogue Scale (VAS).;Consumable Pethidine. Timepoint: Up to 24 hours after surgery. Method of measurement: Patient document.;Consumable Ibuprofen. Timepoint: 1 to 7 days after surgery. Method of measurement: Interview with patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Karimi
Shahroud University of Medical Sciences
Outcome results
None listed